IN THE NEWS
Medical Device Firm Says Sabotage Suit Should Stand
Law360 | June 22, 2019 — Medical device company Neurvana told a Delaware vice chancellor Thursday it has enough to press its claim that Balt damaged potential revenue related to…
Pierce Bainbridge Announces Sergey Grishin Lawsuit Against Jennifer Sulkess For Copyright Infringement And Defamation
Pierce, Bainbridge, Beck, Price & Hecht LLP for PR Newswire | May 22, 2019 — Sergey Grishin has filed a lawsuit in the U.S. District Court for the Central District…
Pierce Bainbridge Continues Record Growth With Addition of Yavar Bathaee as Partner in New York and Park Avenue Office Move
Pierce, Bainbridge, Beck, Price & Hecht LLP for Yahoo! Finance | May 20, 2019 — Pierce Bainbridge Beck Price & Hecht (“Pierce Bainbridge”) is pleased to announce that Yavar Bathaee…
PRACTICE AREAS
Intellectual Property Litigation
Health Care Law
Internal Investigations
Commercial Litigation
NOTABLE REPRESENTATIONS
Represented Amgen in biosimilar litigation pursuant to the Biologics Price Competition and Innovation Act (“BPCIA”) regarding competitors’ proposed filgrastim and proposed pegfilgrastim products.
Represented Spansion in International Trade Commission investigation regarding read/write operations in flash memory devices.
Member of trial team representing Samsung in International Trade Commission investigation regarding LTE/4G wireless communications standards.
Member of trial team representing Motorola in litigation regarding F/RAND royalty rates for patents related to 802.11 (Wi-Fi) and H.264 video compression standards.
Represented Motorola in patent litigation regarding features of graphical user interfaces.
Represented Motorola in patent litigation regarding communications session technology relating to persistent communication sessions across multiple user devices.
Represented GN ReSound regarding wireless communication techniques used in hearing aids.
Represented Wyeth/Pfizer in ANDA litigation regarding broad-spectrum antibiotic.
Represented university client in dispute over joint inventorship of patent related to synthetic peptides.
Represented Goldman Sachs in litigation regarding contract dispute resulting from sale of voice recognition software company.
Represented client in connection with FCPA investigation.
Represented pharmaceutical client in connection with government investigation on drug pricing.
NOTABLE CLIENTS
Amgen
Genetech
Pfizer
Samsung
Motorola Mobility
EDUCATION
J.D., Fordham University School of Law
Ph.D., University of Pennsylvania
A.B., Bowdoin College
PREVIOUS ASSOCIATIONS
Associate
Ropes & Gray LLP
Associate
Paul, Weiss, Rifkind, Wharton & Garrison LLP
ADMISSIONS
State Bar of New York
State Bar of Massachusetts
THOUGHT LEADERSHIP
Panelist, “Best Practices In Patenting Precision Medicine,” at the Life Sciences Patent Network North America’s Spring Conference, April 25, 2019, Boston.
Hiro Hagiwara, Steve Baughman, Gene Lee, Conor McDonough, Joint and Divided Infringement: Navigating the Changing Landscape for Multiple Actors and Distributed Systems under U.S. Patent Law, 62 Japan Int. Prop. Assoc. 265 (2015)
Herman, Kenneth B., Scarpati, Jennifer, McDonough, Conor Brew, Faster Regulatory Path for Follow-On Biologics is a Win for Pharma, 6 Pharma Mag. 46 (2010)
